In Ovations Holdings, Inc. announced the implementation of the technology using sputum cytology for the early detection of lung cancer, a recognized laboratory procedure similar to the 'Pap' test.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
2017 | In Ovations Holdings, Inc. Appoints Kenneth Hughes as Chief Science Officer | CI |
2017 | In Ovations Holdings, Inc. Announces Resignation of Rosendo Alvarez III as Officer and Director | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5.56K | |
+14.58% | 70.29B | |
+6.71% | 17.8B | |
+23.57% | 13.68B | |
+7.64% | 13.15B | |
+19.52% | 10.13B | |
-24.66% | 6.51B | |
-6.71% | 5.86B | |
+0.31% | 5.14B | |
-0.13% | 4.99B |
- Stock Market
- Equities
- INOH Stock
- News In Ovations Holdings, Inc.
- In Ovations Holdings, Inc. Announces the Availability of the Early Detection of Lung Cancer Kit